Iron reduction by phlebotomy for the prevention and treatment of type 2 diabetes
Diabetes, Endocrine (Hormones)
The major goal of the study is to investigate effects of iron overload on insulin resistance. Subjects randomized to control group (no treatment) or phlebotomy (blood donation) to reduce iron load.
IRB Protocol #
Sarah Douglass PA-C at 720-848-7173 or firstname.lastname@example.org
University of Colorado HospitalUniversity of Colorado Hospital
Eligibility and Other Participant Information
•Males and females aged 35-65
•Type 2 diabetes diagnosis
•HbA1c less than 7.5%
•Treated with diet and/or metformin.
•Duration of diagnosis of diabetes < 5 years
•Cancer (except cases currently with no evidence of disease)
•Chronic inflammatory conditions (rheumatologic conditions such as rheumatoid arthritis or giant cell arteritis, or chronic infections such as hepatitis B or C) that could affect ferritin (Iron)
•History of GI bleeding
•Current glucocorticoid therapy